Abstract
Human hepatitis B virus, the leading pathogen for hepatitis B, is a compact DNA virus with viral genes that largely overlap. An increasing number of mutations have emerged following human interventions such as vaccination and anti-viral therapy. While vaccine escape mutants are characterized by mutations on the antigenic hepatitis B surface antigen, those carrying mutations in other viral proteins are either resistant to anti-viral therapy or implicated in acute liver diseases. Molecular identification of these various mutants should shed new lights on the underlying mechanism of hepatitis B virus viral escape and resistance and provide helpful information on their effective eradication.
Original language | English |
---|---|
Pages (from-to) | 237-242 |
Number of pages | 6 |
Journal | FEBS Letters |
Volume | 453 |
Issue number | 3 |
DOIs | |
Publication status | Published - Jun 25 1999 |
Externally published | Yes |
ASJC Scopus Subject Areas
- Biophysics
- Structural Biology
- Biochemistry
- Molecular Biology
- Genetics
- Cell Biology
Keywords
- Anti-viral therapy
- Hepatocellular carcinoma
- Human hepatitis B virus
- Mutation
- Vaccine escape